Annika Jögi

Sökresultat

• 2022

  Breast cancer hypoxia in relation to prognosis and benefit from radiotherapy after breast-conserving surgery in a large, randomised trial with long-term follow-up

  Tutzauer, J., Sjöström, M., Holmberg, E., Karlsson, P., Killander, F., Leeb-Lundberg, L. M. F., Malmström, P., Niméus, E., Fernö, M. & Jögi, A., 2022, I: British Journal of Cancer. 126, 8, s. 1145-1156

  Forskningsoutput: Tidskriftsbidrag › Artikel i vetenskaplig tidskrift › Peer review

  Öppen tillgång

  • Hypoxia-Inducible Factor 1 100%
  • Segmental Mastectomy 90%
  • Hypoxia 62%
  • Radiotherapy 54%
  • Breast Neoplasms 50%
  2 Citeringar (SciVal)
• 2019

  Expression of HIF-1α is related to a poor prognosis and tamoxifen resistance in contralateral breast cancer

  Jögi, A., Ehinger, A., Werner Hartman, L. & Alkner, S., 2019 dec. 10, I: PLoS ONE. 14, 12, e0226150.

  Forskningsoutput: Tidskriftsbidrag › Artikel i vetenskaplig tidskrift › Peer review

  Öppen tillgång

  • Hypoxia-Inducible Factor 1 100%
  • Tamoxifen 84%
  • Transcription Factors 59%
  • Breast Neoplasms 50%
  • Growth Factor Receptors 31%
  28 Citeringar (SciVal)
• 2017

  Hypoxia, pseudohypoxia and cellular differentiation

  Mohlin, S., Wigerup, C., Jögi, A. & Påhlman, S., 2017 juli 15, I: Experimental Cell Research. 356, 2, s. 192-196 5 s.

  Forskningsoutput: Tidskriftsbidrag › Artikel i vetenskaplig tidskrift › Peer review

  • Cell Hypoxia 100%
  • endothelial PAS domain-containing protein 1 80%
  • Transcription Factors 59%
  • Neuroblastoma 39%
  • Hypoxia 31%
  25 Citeringar (SciVal)
• 2016

  HIF2α contributes to antiestrogen resistance via positive bilateral crosstalk with EGFR in breast cancer cells.

  Alam, M. W., Persson, C., Reinbothe, S., Kazi, J. U., Rönnstrand, L., Wigerup, C., Ditzel, H. J., Lykkesfeldt, A. E., Påhlman, S. & Jögi, A., 2016 mars, I: Oncotarget. 7, 10, s. 11238-50

  Forskningsoutput: Tidskriftsbidrag › Artikel i vetenskaplig tidskrift › Peer review

  Öppen tillgång

  • Estrogen Receptor Modulators 100%
  • Breast Neoplasms 49%
  • Estrogen Receptors 20%
  • Hypoxia 13%
  • FM19G11 12%
  16 Citeringar (SciVal)
• 2015

  Differential HIF-1α and HIF-2α Expression in Mammary Epithelial Cells during Fat Pad Invasion, Lactation, and Involution.

  Påhlman, S., Lund, L. R. & Jögi, A., 2015, I: PLoS ONE. 10, 5, e0125771.

  Forskningsoutput: Tidskriftsbidrag › Artikel i vetenskaplig tidskrift › Peer review

  Öppen tillgång

  Fil

  • Human Mammary Glands 100%
  • Lactation 99%
  • Adipose Tissue 75%
  • Breast 69%
  • Epithelial Cells 65%
  14 Citeringar (SciVal)

  148 Nedladdningar (Pure)

• Hypoxia down-regulates expression of secretory leukocyte protease inhibitor in bronchial epithelial cells via TGF-β1.

  Påhlman, L., Jögi, A., Gram, M., Mori, M. & Egesten, A., 2015, I: BMC Pulmonary Medicine. 15, 1, 19.

  Forskningsoutput: Tidskriftsbidrag › Artikel i vetenskaplig tidskrift › Peer review

  Öppen tillgång

  Fil

  • Secretory Leukocyte Peptidase Inhibitor 100%
  • Peptide Hydrolases 53%
  • Hypoxia 50%
  • Epithelial Cells 45%
  • Down-Regulation 44%
  9 Citeringar (SciVal)

  148 Nedladdningar (Pure)

• Spontaneous lung and lymph node metastasis in transgenic breast cancer is independent of the urokinase receptor uPAR

  Almholt, K., Laerum, O. D., Nielsen, B. S., Lund, I. K., Lund, L. R., Romer, J. & Jögi, A., 2015, I: Clinical and Experimental Metastasis. 32, 6, s. 543-554

  Forskningsoutput: Tidskriftsbidrag › Artikel i vetenskaplig tidskrift › Peer review

  • Urokinase-Type Plasminogen Activator 100%
  • Lymph Nodes 62%
  • Breast Neoplasms 56%
  • Neoplasm Metastasis 54%
  • Lung 47%
  7 Citeringar (SciVal)
• 2014

  EPO-independent functional EPO receptor in breast cancer enhances estrogen receptor activity and promotes cell proliferation.

  Reinbothe, S., Larsson, A-M., Vaapil, M., Wigerup, C., Sun, J., Jögi, A., Neumann, D., Rönnstrand, L. & Påhlman, S., 2014, I: Biochemical and Biophysical Research Communications. 445, 1, s. 163-169

  Forskningsoutput: Tidskriftsbidrag › Artikel i vetenskaplig tidskrift › Peer review

  • Erythropoietin 100%
  • Erythropoietin Receptors 98%
  • Estrogen 75%
  • Estrogen Receptors 65%
  • Cell Proliferation 46%
  18 Citeringar (SciVal)
• 2012

  Cancer cell differentiation heterogeneity and aggressive behavior in solid tumors.

  Jögi, A., Vaapil, M., Johansson, M. & Påhlman, S., 2012, I: Uppsala Journal of Medical Sciences. 117, 2, s. 217-224

  Forskningsoutput: Tidskriftsbidrag › Artikel i vetenskaplig tidskrift › Peer review

  Öppen tillgång

  • Cell Differentiation 100%
  • Neoplasms 39%
  • Surgical Pathology 25%
  • Neoplastic Stem Cells 21%
  • Neuroblastoma 10%
  101 Citeringar (SciVal)

• Hypoxic conditions induce a cancer-like phenotype in human breast epithelial cells.

  Vaapil, M., Helczynska, K., Villadsen, R., Petersen, O. W., Johansson, E., Beckman, S., Larsson, C., Påhlman, S. & Jögi, A., 2012, I: PLoS ONE. 7, 9, e46543.

  Forskningsoutput: Tidskriftsbidrag › Artikel i vetenskaplig tidskrift › Peer review

  Öppen tillgång

  Fil

  • Hypoxia 100%
  • Breast 96%
  • Epithelial Cells 90%
  • Tumor Hypoxia 84%
  • Breast Neoplasms 80%
  26 Citeringar (SciVal)

  139 Nedladdningar (Pure)
• 2011

  Protein kinase Cα suppresses the expression of STC1 in MDA-MB-231 breast cancer cells

  Cornmark, L., Kalstad Lönne, G., Jögi, A. & Larsson, C., 2011, I: Tumour Biology. 32, 5, s. 1023-1030

  Forskningsoutput: Tidskriftsbidrag › Artikel i vetenskaplig tidskrift › Peer review

  • Protein Kinase C 100%
  • Breast Neoplasms 67%
  • Hypoxia 31%
  • teleocalcin 22%
  • protein kinase C kinase 18%
  8 Citeringar (SciVal)
• 2010

  Neutralisation of uPA with a monoclonal antibody reduces plasmin formation and delays skin wound healing in tPA-deficient mice.

  Jögi, A., Rønø, B., Lund, I. K., Nielsen, B. S., Ploug, M., Høyer-Hansen, G., Rømer, J. & Lund, L. R., 2010, I: PLoS ONE. 5, 9, s. e12746

  Forskningsoutput: Tidskriftsbidrag › Artikel i vetenskaplig tidskrift › Peer review

  Öppen tillgång

  • Fibrinolysin 100%
  • Plasminogen Activators 98%
  • Urokinase-Type Plasminogen Activator 95%
  • Wound Healing 73%
  • Monoclonal Antibodies 61%
  23 Citeringar (SciVal)

• Neutralization of uPA with a Monoclonal Antibody Reduces Plasmin Formation and Delays Skin Wound Healing in tPA-Deficient Mice

  Jögi, A., Rønø, B., Lund, I. K., Nielsen, B. S., Ploug, M., Høyer-Hansen, G., Rømer, J. & Lund, L. R., 2010, I: PLoS ONE. 5, 9, s. e12746

  Forskningsoutput: Tidskriftsbidrag › Artikel i vetenskaplig tidskrift › Peer review
• 2009

  Nuclear expression of the RNA-binding protein RBM3 is associated with an improved clinical outcome in breast cancer.

  Jögi, A., Brennan, D. J., Rydén, L., Magnusson, K., Fernö, M., Stål, O., Borgquist, S., Uhlen, M., Landberg, G., Påhlman, S., Pontén, F. & Jirström, K., 2009, I: Modern Pathology : an official journal of the United States and Canadian Academy of Pathology, Inc. 22, s. 1564-1574

  Forskningsoutput: Tidskriftsbidrag › Artikel i vetenskaplig tidskrift › Peer review

  • Nuclear RNA 100%
  • RNA-Binding Proteins 85%
  • Breast Neoplasms 47%
  • Neoplasms 23%
  • Estrogen Receptors 19%
  63 Citeringar (SciVal)
• 2008

  Antibody-mediated targeting of the urokinase-type plasminogen activator proteolytic function neutralizes fibrinolysis in vivo.

  Lund, I. K., Jögi, A., Rønø, B., Rasch, M. G., Lund, L. R., Almholt, K., Gårdsvoll, H., Behrendt, N., Rømer, J. & Høyer-Hansen, G., 2008, I: Journal of Biological Chemistry. 283, 47, s. 32506-32515

  Forskningsoutput: Tidskriftsbidrag › Artikel i vetenskaplig tidskrift › Peer review
  35 Citeringar (SciVal)

• Prognostic impact of tumour-specific HMG-CoA reductase expression in primary breast cancer

  Borgquist, S., Jögi, A., Ponten, F., Rydén, L., Brennan, D. J. & Jirström, K., 2008, I: Breast Cancer Research. 10, 5, R79.

  Forskningsoutput: Tidskriftsbidrag › Artikel i vetenskaplig tidskrift › Peer review

  Öppen tillgång

  • Hydroxymethylglutaryl CoA Reductases 100%
  • Coenzyme A 80%
  • Oxidoreductases 59%
  • Breast Neoplasms 46%
  • Neoplasms 23%
  50 Citeringar (SciVal)
• 2007

  Murine monoclonal antibodies against murine uPA receptor produced in gene-deficient mice: inhibitory effects on receptor-mediated uPA activity in vitro and in vivo

  Pass, J., Jögi, A., Lund, I. K., Rono, B., Rasch, M. G., Gardsvoll, H., Lund, L. R., Ploug, M., Romer, J., Dano, K. & Hoyer-Hansen, G., 2007, I: Thrombosis and Haemostasis. 97, 6, s. 1013-1022

  Forskningsoutput: Tidskriftsbidrag › Artikel i vetenskaplig tidskrift › Peer review

  • Urokinase Plasminogen Activator Receptors 100%
  • Plasminogen Activators 63%
  • Urokinase-Type Plasminogen Activator 61%
  • anthrax toxin 52%
  • Monoclonal Antibodies 52%
  28 Citeringar (SciVal)

• Systemic administration of anti-urokinase plasminogen activator receptor monoclonal antibodies induces hepatic fibrin deposition in tissue-type plasminogen activator deficient mice

  Jögi, A., Pass, J., Hoyer-Hansen, G., Lund, L. R., Nielsen, B. S., Dano, K. & Romer, J., 2007, I: Journal of Thrombosis and Haemostasis. 5, 9, s. 1936-1944

  Forskningsoutput: Tidskriftsbidrag › Artikel i vetenskaplig tidskrift › Peer review

  • Urokinase Plasminogen Activator Receptors 100%
  • Tissue Plasminogen Activator 76%
  • Fibrin 73%
  • Plasminogen Activators 52%
  • Monoclonal Antibodies 52%
  20 Citeringar (SciVal)
• 2005

  HIF-2alpha expression in human fetal paraganglia and neuroblastoma: relation to sympathetic differentiation, glucose deficiency, and hypoxia.

  Nilsson, H., Jögi, A., Beckman, S., Harris, A. L., Poellinger, L. & Påhlman, S., 2005, I: Experimental Cell Research. 303, 2, s. 447-456

  Forskningsoutput: Tidskriftsbidrag › Artikel i vetenskaplig tidskrift › Peer review
  63 Citeringar (SciVal)

• Phenotypic persistence after reoxygenation of hypoxic neuroblastoma cells.

  Holmquist Mengelbier, L., Jögi, A. & Påhlman, S., 2005, I: International Journal of Cancer. 116, 2, s. 218-225

  Forskningsoutput: Tidskriftsbidrag › Artikel i vetenskaplig tidskrift › Peer review
  45 Citeringar (SciVal)
• 2004

  Human neuroblastoma cells exposed to hypoxia: induction of genes associated with growth, survival, and aggressive behavior.

  Jögi, A., Vallon-Christersson, J., Holmquist Mengelbier, L., Axelson, H., Borg, Å. & Påhlman, S., 2004, I: Experimental Cell Research. 295, 2, s. 469-487

  Forskningsoutput: Tidskriftsbidrag › Artikel i vetenskaplig tidskrift › Peer review
  101 Citeringar (SciVal)

• Induction of ID2 expression by hypoxia-inducible factor-1: ARole in dedifferentiation of hypoxic neuroblastoma cells.

  Löfstedt, T., Jögi, A., Sigvardsson, M., Gradin, K., Poellinger, L., Påhlman, S. & Axelson, H., 2004, I: Journal of Biological Chemistry. 279, 38, s. 39223-39231

  Forskningsoutput: Tidskriftsbidrag › Artikel i vetenskaplig tidskrift › Peer review

  Öppen tillgång

  Fil

  • Hypoxia-Inducible Factor 1 100%
  • Neuroblastoma 78%
  • Hypoxia 62%
  • Binding Site 55%
  • Neural Crest 36%
  120 Citeringar (SciVal)

  418 Nedladdningar (Pure)
• 2003

  Hypoxia-induced dedifferentiation in neuroblastoma cells.

  Jögi, A., Øra, I., Nilsson, H., Poellinger, L., Axelson, H. & Påhlman, S., 2003, I: Cancer Letters. 197, 1-2, s. 145-150

  Forskningsoutput: Tidskriftsbidrag › Artikel i vetenskaplig tidskrift › Peer review

  Öppen tillgång
  38 Citeringar (SciVal)

• Hypoxia promotes a dedifferentiated phenotype in ductal breast carcinoma in situ.

  Helczynska, K., Kronblad, Å., Jögi, A., Nilsson, E., Beckman, S., Landberg, G. & Påhlman, S., 2003, I: Cancer Research. 63, 7, s. 1441-1444

  Forskningsoutput: Tidskriftsbidrag › Artikel i vetenskaplig tidskrift › Peer review
  173 Citeringar (SciVal)
• 2002

  Hypoxia alters gene expression in human neuroblastoma cells toward an immature and neural crest-like phenotype.

  Jögi, A., Øra, I., Nilsson, H., Lindeheim, Å., Makino, Y., Poellinger, L., Axelson, H. & Påhlman, S., 2002, I: Proceedings of the National Academy of Sciences. 99, 10, s. 7021-7026

  Forskningsoutput: Tidskriftsbidrag › Artikel i vetenskaplig tidskrift › Peer review

  Öppen tillgång

  • Neural Crest 100%
  • Neuroblastoma 86%
  • endothelial PAS domain-containing protein 1 83%
  • Hypoxia 67%
  • Phenotype 51%
  316 Citeringar (SciVal)

• Modulation of Basic Helix-Loop-Helix Transcription Complex Formation by Id Proteins during Neuronal Differentiation.

  Jögi, A., Persson, P., Grynfeld, A., Påhlman, S. & Axelson, H., 2002, I: Journal of Biological Chemistry. 277, 11, s. 9118-9126

  Forskningsoutput: Tidskriftsbidrag › Artikel i vetenskaplig tidskrift › Peer review

  Öppen tillgång

  • Neuroblastoma 100%
  • Protein 96%
  • Proteins 86%
  • Basic Helix-Loop-Helix Transcription Factors 45%
  • Neural Crest 38%
  81 Citeringar (SciVal)
• 2000

  HASH-1 and E2-2 are expressed in human neuroblastoma cells and form a functional complex

  Persson, P., Jögi, A., Grynfeld, A., Påhlman, S. & Axelson, H., 2000, I: Biochemical and Biophysical Research Communications. 274, 1, s. 22-31

  Forskningsoutput: Tidskriftsbidrag › Artikel i vetenskaplig tidskrift › Peer review

  • Complementary DNA 100%
  • Neuroblastoma 95%
  • Mammalian Cell 49%
  • Central Nervous System 47%
  • Basic Helix-Loop-Helix Transcription Factors 44%
  54 Citeringar (SciVal)

• Patched 2, located in 1p32-34, is not mutated in high stage neuroblastoma tumors

  Jögi, A., Abel, F., Sjoberg, R. M., Toftgard, R., Zaphiropoulos, P. G., Påhlman, S., Martinsson, T. & Axelson, H., 2000, I: International Journal of Oncology. 16, 5, s. 943-949

  Forskningsoutput: Tidskriftsbidrag › Artikel i vetenskaplig tidskrift › Peer review

  • Neuroblastoma 100%
  • Neoplasms 32%
  • myc Genes 20%
  • Chromosomes, Human, Pair 1 20%
  • Loss of Heterozygosity 19%
  7 Citeringar (SciVal)